Skip to main content
Mezzion Pharma Co., Ltd. logo

Mezzion Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 140410 ISIN · KR7140410002 KO Manufacturing
Open in API
Filings indexed 218 across all filing types
Latest filing 2026-04-30 Capital/Financing Update
Country KR South Korea
Listing KO 140410

About Mezzion Pharma Co., Ltd.

https://mezzion.com

Mezzion Pharma Co., Ltd. is an innovation-driven pharmaceutical company focused on discovering, developing, and commercializing novel therapeutics for rare diseases. The company's primary efforts are concentrated on addressing the unmet medical needs of individuals with a Fontan circulation, a palliative surgical procedure for single-ventricle heart defects. Its lead drug candidate, udenafil, is being advanced as a potential first-to-market treatment to improve the physiology of the Fontan circulation. Mezzion is conducting late-stage clinical development, including a confirmatory Phase 3 trial (FUEL-2), to evaluate the therapy's efficacy in adolescent patients.

Recent filings

Filing Released Lang Actions
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a "주요사항보고서(전환사채권 발행결정)" filed with the Financial Supervisory Service/Korea Exchange, detailing the decision to issue KRW 36.5 billion of convertible bonds, including terms, interest rates, conversion price, put and call options, and underwriting arrangements. This is an update on the company’s financing and capital structure. It is not an earnings release, management discussion, or a proxy statement but a financing event disclosure. Therefore, it should be classified as a Capital/Financing Update (CAP).
2026-04-30 Korean
소송등의판결ㆍ결정(일정금액이상의청구)
Legal Proceedings Report Classification · 1% confidence The document is a corporate disclosure in Korean detailing the outcome of a court judgement (‘소송등의판결ㆍ결정’) on a significant claim against the company, including case number, parties, decision, amounts, court, and next steps. This fits the definition of a Legal Proceedings Report (updates on significant lawsuits and legal matters).
2026-04-17 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is the official results of a company’s regular shareholders’ meeting (Annual General Meeting) held on 2026-03-30, providing vote counts, approval status for each agenda item, and related resolutions. This matches the “Declaration of Voting Results & Voting Rights Announcements” category (DVA).
2026-03-30 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'Mezzion' (주식회사 메지온) for the fiscal year ending December 31, 2025. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. This is a comprehensive financial audit document, not an annual report (10-K) which would include management discussion and analysis (MD&A) and business overview, nor is it a short announcement. Therefore, it is classified as an Audit Report. FY 2025
2026-03-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (purchases) made by an executive (No Seong-il) of the company Mezzion. This type of filing is a standard disclosure for insider trading/director dealings in the Korean market, which corresponds to the 'Director's Dealing' category.
2026-03-18 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal announcement titled '감사보고서 제출' (Submission of Audit Report) filed by the company Mezzion. It provides a summary of the audit opinion (which is 'unqualified' or '적정'), key financial data (assets, liabilities, equity, revenue, profit/loss), and details regarding the external auditor. While it contains financial data, it is a regulatory disclosure announcement summarizing the audit results rather than the full annual report itself. According to the 'Menu vs Meal' rule, this is a notification of the audit report's submission, which falls under the category of Regulatory Filings (RNS) as it is a standard corporate disclosure announcement in the Korean market. FY 2025
2026-03-16 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.